InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Browse the detailed record of transactions filed by Moretti August J. Director active across 1 company, notably 4D Molecular Therapeutics, Inc.. In total, 2 disclosures have been published. Activity tracked since 21 December 2022. The latest transaction was filed on 15 May 2023 (Levée d'options). Regulator: SEC (Form 4). The full history is accessible without signup.
2 of 2 declarations